Gerald A. Jordan, M.D.
Project Director, Chairman Board of Advisors and Chairman Medical Scientific Board

Dr. Jordan is a noted leader in the field of urology. He received his B.S. degree from the United States Naval Academy (in Annapolis) in aeronautical engineering (with merit), completed his Pre-Med at the United States International University (at Cal Western), and his M.D. degree from the University of Texas Health Sciences Center (at San Antonio). He completed his internship and residency in basic Surgery and urology, respectively, at the Naval Regional Medical Center (in Portsmouth, VA), and went on to complete several other post-graduate advanced surgical courses including a Fellowship in Pediatric and Adult Reconstructive Urology at the Eastern Virginia Graduate School of Medicine, his current affiliation. Dr. Jordan has garnered numerous appointments in his long, and distinguished service in the U.S. Armed Forces, and achieved the rank of Commander in the U.S. Naval Reserve. In 1984, he was certified by the American Board of Urology in the Specialty of Adult and Pediatric Urology. Dr. Jordan has been an instructor for most of his professional career at the Eastern Virginia Medical School, currently designated as a Professor of Urology at that institution. He had served as the Chairman of that Department (from July 2000 to December 2003). Dr. Jordan has been involved on the Editorial Boards, or as an Abstract Reviewer for numerous urology publications including the Journal of Urology, the British Journal of Urology and UROLOGY. He has published over 350 articles and extracts for leading urology publications, and has created dozens of educational videos in the field of urology. As a result, Dr. Jordan has been sought out by professional organizations throughout the world as an expert lecturer on a wide variety of topics related to urology (incl. urinary incontinence), and is recognized for his particular expertise relating to the damage and repair of the urethra. He has given over 500 such lectures throughout the world. Dr. Jordan also has been the Principal, or sub Investigator in dozens of research projects for many of the premier companies in the urology space, and has a particularly extensive background in using and reviewing the functionality of many of our Company’s competing products. He holds professional membership in, or honorary appointments to, over 30 medical organizations in both the U.S. and internationally. He has been the past President of the following organizations; the Virginia Urological Society, the Society of Genitourinary Reconstructive Surgeons and the Virginia Chapter of the American College of Surgeons, and is listed as a Life Member in the Who’s Who in America.

Angelo Gousse, M.D.
Medical Scientific Board Member and Chief of Surgery
Dr. Gousse is a former tenured Professor of Urology at the University of Miami Miller School of Medicine, Department of Urology, Vice-Chairman of the University of Miami Hospital and Clinics Urology service, where he was also the Urology Residency Program Director and Fellowship Director for Female Urology, Urodynamics, and Reconstructive Surgery and the Director of the Urodynamics Laboratory at the VA Medical Center for ten years. After graduating as the valedictorian of the City University of New York (York College) with a perfect GPA in his major, Dr. Gousse received his medical degree with highest honors from the Yale University School of Medicine. He completed his residency at the Baylor College of Medicine in Houston and a postdoctoral fellowship in urodynamics, female urology, and pelvic floor reconstruction at the University of California Los Angeles. He is certified by the American Board of Urology. Dr. Gousse’s research interests have focused on overactive bladder neuropharmacology, reconstruction, neurogenic urinary incontinence, as well as functional recovery from spinal cord injury. An international leader in voiding dysfunction, he has pioneered the optimal dosage of neurotoxins to manage bladder dysfunction. Over the past seven years, he has collaborated on extramural NIH grants with basic scientists to investigate urinary markers for interstitial cystitis. He has authored or co-authored more than 60 peer-reviewed scientific publications and numerous textbook chapters, journal articles, and abstracts, and has participated as a guest professor in the United States and abroad on various aspects of reconstructive urology. For many years, he has been the Section Editor of the Female Urology section in the journal Current Urology Reports. Recently appointed as a Board Member of the Urodynamics Society (SUFU), he also serves on the AUA Female Urology Core Curriculum Committee. His professional awards and honors include a listing in Best Doctors in America 2005 to 2010, America’s Top Urologists by the prestigious Consumer’s Research Council of America 2008, Strathmore’s Who’s Who since 2001, the Miller University of Miami Medical School’s Urology Teacher of the Year Award on numerous occasions, the Pfizer Scholars in Urology Award, and the Cullen Research Award from the Scott Department of Urology, Baylor College of Medicine, and the Dr. Jonas Salk Scholar Award for his work on E.coli microbial genetics. He is also the co-founder and president of the Haitian American Leadership Organization (HALO).

Ballentine Carter, M.D.
Medical Scientific Board Member

Dr. Carter is an internationally recognized expert in the diagnosis and treatment of prostate disease, both cancerous and non- cancerous. He began his career by obtaining his B.S. degree from Furman University in biology (in 1975) and his M.D. degree from the Medical University of South Carolina (in Charleston in 1981). He completed his internship and residency as an Assistant Resident in both surgery and urology in the departments of surgery and urology at the New York Hospital (in New York, NY) from 1981-1986, and went on to became the Chief Resident there in the Department of Urology (1986-1987) and then completed his Fellowship in Urology at the Johns Hopkins School of Medicine (Baltimore, MD; 1987-1989), his current affiliation, by way of an American Urological Association (AUA) scholarship. In 1984, he was certified by the American Board of Urology in the Specialty of Adult Urology. Dr. Carter has been an instructor for most of his professional career at the Johns Hopkins School of Medicine, beginning as an Instructor (in 1987) and then rising to his current position as a Professor of Urology and Oncology and the Head of the Adult Urology Division at that institution. Dr. Carter has been a member of numerous hospital and national committees over the years especially focused on prostate cancer, as well as, having been awarded a number of academic honors including the Distinguished Contribution Award from the AUA (in 2014). He has been appointed to a number of editorial positions, including the Guest editor of the World Journal of Urology (in 1997) and continues as a Consulting Editor of the journal Urology (since 1998). Dr. Carter has presented (to date) 155 lectures worldwide, has had published 225 articles in key urology journals, has been a main contributor of chapters published in 33 key urology texts and has also been a main contributor of abstracts published in key urological forums. He has also conducted significant research in a variety of urological-based projects. As a clinician/surgeon, Dr. Carter has performed over 3,500 radical prostatectomies with outcomes that return many of his patients to a life that was present before the diagnosis of prostate cancer.  In 1995, Dr. Carter began a large prospective study to evaluate what is now referred to as Active Surveillance for prostate cancer – a program designed to select men who are thought to have small volume cancers that may never need treatment. Additionally, in 2013, he led a panel of experts that wrote the American Urological Association guidelines for prostate cancer detection. His book –The Whole Life Prostate Book– is the only comprehensive prostate book for laypeople that offers patients not only up to date information on management options for prostate disease (including cancer), but also approaches to prevention of male health disorders including prostate disease.  He was nominated to be a Trustee of the American Board of Urology by the American Association of Genitourinary Surgeons. His term extends from February 2012-February 2018. Dr. Carter’s election as a Trustee to the American Board of Urology is a recognition of his exemplary patient care and innovative research in the field of prostate cancer. The concept of PSA rate of change (PSA velocity) as a marker of prostate cancer presence and aggressiveness, was introduced by Dr. Carter in collaboration with investigators at the Baltimore Longitudinal Study of Aging. He also first described the use of free PSA to predict the behavior of prostate cancer. He was the first to publish data demonstrating that an individual’s personal prostate cancer screening program should be tailored to baseline PSA levels instead of using a “one size fits all” approach. Together with investigators at the Baltimore Longitudinal Study of Aging, Dr. Carter has investigated risk factors for development of prostate cancer and prostate enlargement including diet and life style. 

Timothy Boone, M.D., Ph.D.
Medical Scientific Board Member

Dr. Timothy B. Boone is the Chair of the Urology Department, Co-Director of the Institute for Academic Medicine and a member of the Neurological Institute at Houston Methodist Hospital. He is Professor of Urology at Weill Cornell Medical College and holds appointments as Professor of Urology at Texas A&M College of Medicine and Baylor College of Medicine where he is a Clinical Professor of Urology. In 2014, Dr. Boone was appointed Vice Dean, Texas A&M University College of Medicine at the Houston campus. Dr. Boone earned his Master of Science in physiology and Ph.D. in neuroscience at the University of Texas Graduate School of Biomedical Sciences at Houston. He completed his M.D./Ph.D. at the University of Texas Medical School at Houston and urology residency training at the University of Texas Southwestern Medical School in Dallas. In 1991 he joined the faculty in the Department of Urology at UT Southwestern for two years and then moved to Baylor College of Medicine where he joined the Scott Department of Urology. In 2000 Dr. Boone was named Professor and Chair of the Scott Department of Urology where he served until 2008. For over 20 years he has actively participated in the care of spinal cord injured veterans with neurogenic bladder dysfunction at the VA Spinal Cord Injury Unit in Dallas and in Houston. Dr. Boone specializes in the treatment of patients with incontinence following prostatectomy, women with complex voiding disorders, and bladder problems related to neurologic disease including spinal cord injury, stroke, multiple sclerosis, and Parkinson’s disease. He maintains active participation in research, focusing on mechanisms of sensory control and dysfunction in the bladder and urethra that are related to spinal cord injury, diabetes or obstruction. Dr. Boone is the Primary Investigator for the Neuroregeneration and Bladder Sensory Science Laboratory at the Houston Methodist Research Institute. Throughout his career Dr. Boone has written over 100 publications and given hundreds of lectures regionally and nationally while serving as a visiting professor for many departments of urology. He is a member of the American Association of Genitourinary Surgeons, Clinical Society of GU Surgeons, American Urological Association, Texas Urological Society, Society for Neuroscience, Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, and the AOA Honor Medical Society. He serves as consultant reviewer for several scientific journals including Neurourology and Urodynamics, Journal of Urology, British Journal of Urology, Urology, Spinal Cord, and the New England Journal of Medicine. He is on the editorial board of Nature Reviews in Urology. Dr. Boone was elected as a Trustee to the American Board of Urology in 2006 and served as President of the American Board of Urology from 2011 – 2012.

J. Christian Winters, M.D.
Medical Scientific Board Member
Dr. Winter currently serves as the Vice Chancellor for Clinical Affairs, Interim CEO and Chairman and Professor, Department of Urology of the LSU HealthCare Network. A native of New Orleans, Dr. Winters earned his medical degree from Louisiana State University Medical Center in New Orleans. He completed his urology residency in the combined LSU/ Ochsner program, where he served as Chief Resident and Assistant Clinical Director at Charity Hospital. He then completed a fellowship in female urology and voiding dysfunction at the Cleveland Clinic Foundation in Ohio in 1995.  He returned to LSU in 1997. He was appointed Program Director of the Ochsner /LSU Urology Residency Program in 2005, and was recently recognized by the American Urological Association (AUA) as Teacher of the Year in 2009 for these efforts. He is currently the H. Eustis Reily Professor of Urology and Gynecology and Chairman of the Department of Urology at the Louisiana State University Health Sciences Center in New Orleans, Louisiana.  He also serves as director of the LSU Female Pelvic Medicine and Reconstructive Surgery fellowship, which is involved in the multidisciplinary training of urologist and gynecologists in the field of Female Pelvic Medicine and Reconstructive Surgery. He is Board Certified in Urology, and was appointed as a Trustee to the American Board of Urology in 2011. Dr. Winters is President of the Society of Urodynamics and Female Urology, a Councilor of the Society of University Urologist and a member of: The American Urological Association, the Southeastern Section of the AUA, the International Continence Society, the American Urogynecologic Society, the American College of Surgeons, the International Urogynecologic Association and the Louisiana State Urologic Society. He has served on the Executive Committee of the Southeastern Section of the AUA and as President of the Louisiana State Urologic Society. He was director of the SUFU Fellowship Committee, and during that time was influential in organizing the combined ABU/ABOG match process for Female Pelvic Medicine Fellowships. In addition, he served as a member of the joint ABU/AUA Examination Committee. He has taken an active role in the AUA Health Policy Council, where he serves as Vice- Chair of the SESAUA Health Policy Council and as the SESAUA representative to the AUA Health Policy Council. He was a member of the recently completed American Urologic Association Stress Urinary Incontinence Guidelines Panel. He currently serves as Panel Chair of the AUA Urodynamics Guidelines Panel and panelist in the AUA-ABOG Stress Urinary Incontinence Outcomes Measures Panel. In addition, he serves on the Quality Improvement and Patient Safety Committee as well as the Practice Management Committee of the AUA. Through these roles, he has frequently consulted in the area of voiding dysfunction and female urology. He was the lead author of the AUA Core Curriculum in Urodynamics, and serves as a Core Curriculum Section Editor in the area of Female Urology and Voiding Dysfunction. He remains on the Core Curriculum Education Committee. Dr. Winters also serves as a Senior Editor for UCUR, the Urodynamics Curriculum for Urodynamics Residents, which is a joint project of the SUCPD and SUFU. Dr. Winters served as Associate Editor of Neuro-urology and Urodynamics and is on the editorial board of the Journal of the Louisiana State Medical Society. He reviews for nearly every major journal in the subspecialty of voiding dysfunction and has published over 100 peer-reviewed manuscripts and text chapters. Dr. Winters’ work includes extensive publications regarding techniques and outcomes of the sacral colpopexy procedures, and he was one of the outcomes of the sacral colpopexy procedure, and he was one of the first to report on recurrent prolapse following this procedure.  In addition, he has published extensively on graft biomechanics and histology and is recognized as a leader in graft technology on vaginal surgery. This work has facilitated his advisory roles with the AUA in these areas, and he has represented the AUA before the FDA advisory panel. Dr. Winters has lectured extensively from the podium at the AUA, and has delivered state-of-the art lectures at the Canadian Urologic Society, SUFU, SESAUA, and the International Continence Society.

Jay Bishoff, M.D.
Medical Scientific Board Member
Dr. Bishoff is a nationally recognized expert in minimally invasive surgeries. He obtained his M.D. degree from the Uniformed Services University of The Health Sciences – Bethesda, in Doctor of Medicine in 1991, and went on to complete his internship in general surgery and residency training in urology at the Wilford Hall USAF Medical Center, Lackland Air Force Base from 1991 to 1997. He then completed a fellowship in urology at Johns Hopkins Medical Center – Brady Urologic Institute (Baltimore) in 1998. Dr. Bishoff is board certified by the American Board of Urology and is a member of the American College of Surgeons, American Urological Association and Endourological Society. He is currently the Director of the Intermountain Urological Institute and is also a member of the Huntsman-Intermountain Cancer Care Program. Additionally, Dr. Bishoff has advanced, fellowship training in the latest minimally invasive techniques, including robotics, laparoscopy, cryotherapy and radio frequency ablation, and kidney stones. He has authored four books and is a contributing author of 25 book chapters and over 110 articles.

Margit Fisch, M.D.
Medical Scientific Board Member
Dr. Fisch is one of the most recognized leaders in the field of urology in the world especially in the areas of pediatric urology and complex reconstructive surgery. She studied at the Medical School, University of Saarland (Germany) and was staff member of the Department of Urology, at the University of Mainz, Medical School, Germany and Head Department of Urology and Pediatric Urology, AK Hamburg (Hamburg, Germany). From 2000 to 2001 she was president of the Society of Genitourinary Reconstructive Surgeons (GURS) and from 2002 to 2009 president of the European Society of Genitourinary Reconstructive Surgeons (ESGURS) She is currently Director and Chair at the Department of Urology and Pediatric Urology, University Medical Center Hamburg-Eppendorf (Germany), which has a special focus in the areas Dr. Fisch has her expertise.

John Klutke, M.D.
Medical Scientific Board Member
Dr. Klutke is a recognized expert in the field of obstetrics and gynecology, with special expertise in uro-gynecology. He obtained his M.D. degree from the Rosalind Franklin University of Medicine & Science in1989, then went on to complete his residency program in obstetrics and gynecology at the Cook County Hospital in 1993. He completed his Fellowship in uro-gynecology at LA Campus/University of Southern California Medical Center in 1995. He is an Assistant Professor of Clinical Obstetrics and Gynecology at the University of Southern California, School of Medicine with a special expertise in urinary incontinence (UI), stress (UI) and urologic surgical procedures. Dr. Klutke has published numerous papers and articles in major urological periodicals and journals relating to his areas of expertise.

Carl Klutke, M.D.
Medical Scientific Board Member
Dr. Klutke is recognized as an expert in the field of urology with a special emphasis on urologic surgery, female urology and uro-gynecology. He obtained his M.D. degree from the University Of Michigan (Ann Arbor, Michigan) in 1983 and went on to complete his residency training in both surgery and urology at the Department of Surgery, Henry Ford Hospital (Detroit, Michigan) in 1985 and 1988, respectively. He then completed his fellowship in urology, urodynamics and female urology at the Department of Surgery, University of California (Los Angeles, California) in 1989. His areas of clinical interest include urodynamics, interstitial cystitis, incontinence, vaginal prolapse, gynecologic ureteral injury, stress injury incontinence, urethral diverticula, cystocele, endosurgery for incontinence, bowel and bladder problems, pelvic floor reconstruction, urogynecology and voiding dysfunction in men and women. Dr. Klutke is board certified in urology and is a professor of urologic surgery at the Washington University School of Medicine (in Missouri). He has been listed in several “Best Doctors” compendiums and has numerous publications in his area of expertise including articles, books and book chapters. He has also been the Associate Editor of the Canadian Journal of Urology, and Guest Editor of the Journal of Endourology, the Journal of Urology, the Urologic Clinics of North America and the publication, Urology.

Sender Herschorn, BSc, MDCM, FRCSC
Medical Scientific Board Member
Dr. Sender Herschorn is Professor in the Division of Urology at the University of Toronto and attending Urologist and Head of the Urodynamics Laboratory at Sunnybrook Health Sciences Centre. He completed an 11-year term as University Chair and holder of the Martin Barkin Chair in Urological Research. He is Chair of the University of Toronto Department of Surgery Academic Promotions Committee and is a Past-President of the Canadian Urological Association. He is the current General Secretary of the International Continence Society. Dr. Herschorn has been a senior investigator in clinical trials relating to functional urology. He has won undergraduate, postgraduate, and continuing education awards at the University of Toronto as well as the Zimskind Award of the Society for Urodynamics and Female Urology. He won the W.T. Aikins award from the University of Toronto Faculty of Medicine for excellence in undergraduate medical teaching. He has been the Director of the U of T Urology Update since its inception in 1992. He is the 2010 recipient of the Lifetime Achievement Award from the Society for Urodynamics and Female Urology. Dr. Herschorn has produced many scientific publications, among them the chapters on Vaginal Surgery for Prolapse and Incontinence for 2 editions of Campbell’s Urology and on Injectables for Urinary Incontinence for the most recent edition. He is an Editorial Board Member of Canadian Urological Association Journal and Neurology and Urodynamics. He is a member of the Canadian Male Sexual Health Council. He was Chair of the Committee on Vesico-urethral Stenosis after Treatment for Prostate Cancer at the First International Consultation on Urethral Stricture Disease and Chair of the Committee on Surgery for Male Incontinence at the five International Consultations on Urinary Incontinence. Dr. Herschorn has delivered presentations and lectures throughout Canada and in the United States, Europe, Asia, Australasia, and South America.

John A. Libertino, M.D.
Medical Scientific Board Member
Dr. John Libertino was the former Vice-Chairman of the Institute of Urology at Lahey Clinic in Burlington, Massachusetts. He has served in that role from 1991-2008, leading its team as an international center of excellence in patient care, research, and education. As a surgeon, Dr. Libertino has pioneered some of the most complex surgeries involving urologic tumors. In 2002, the Wall Street Journal identified Dr. Libertino as one of five top urologic surgeons in the US in the area of prostate nerve-sparing surgery. Dr. Libertino previously served as Lahey Clinics chief executive officer, chair of the Division of Surgery and chair of Lahey Clinics Board of Governors. He currently serves as vice chair of Lahey Clinics Board of Trustees. A graduate from Georgetown University School of Medicine, Dr. Libertino completed a residency in urology at Yale New Haven Medical Center, a cardiovascular research fellowship at Georgetown University School of Medicine and a Harvey Cushing Fellowship in Surgery at Yale University School of Medicine. He has authored numerous articles and abstracts for major medical periodicals and published a number of important books in his area of expertise.